Skip to main content

Palo Alto startup Medable scores $91M as it helps to speed Covid vaccine trials

The company says its technology has helped accelerate development of vaccines and therapeutics for Covid-19.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.